Safety and efficacy of temsirolimus in combination with three different immuno-chemotherapy regimens in relapse and refractory mantle cell lymphoma, final results of the T3 phase IB trial of the LYSA
Tessoulin, Benoît, Bouabdallah, Kamal, Burroni, Barbara, Lamy, Thierry, Gressin, Remy, Cartron, Guillaume, Thieblemont, Catherine, Sarkozy, Clémentine, Haioun, Corinne, Casasnovas, Olivier, Joubert,Journal:
Annals of Hematology
DOI:
10.1007/s00277-020-04159-3
Date:
June, 2020
File:
PDF, 528 KB
2020